TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
CRLBF

Cresco Labs Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.6445$ +0.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CRLBF
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – 6.6% 50.1% 40.4% 50.5% 51.7% 53.0% 49.7% 50.5%
– – 93.4% 49.9% 59.6% 49.5% 48.3% 47.0% 50.3% 49.5%
– – 72.2% 69.8% 37.8% 38.7% 41.6% 35.6% 35.2% 37.7%
– – 84.7% 126.7% 88.3% 89.3% 93.2% 91.8% 84.9% 88.3%
– – 15.3% -26.7% 11.7% 10.7% 6.8% 8.2% 15.1% 11.7%
– – 0.2% 7.4% 8.6% 6.3% 6.9% 8.3% 7.9% 9.2%
– – 17.3% -39.6% 1.5% -31.2% -15.1% -19.1% -1.5% -14.5%
– – 10.1% 11.3% 6.0% 4.9% 10.6% – – –
– – -4.4% -33.6% -17.2% -38.9% -25.2% -22.8% -10.3% -20.6%
– – 20.3% -22.9% 18.5% -19.4% -1.3% -1.8% 15.6% 3.1%

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?